Lonza Licenses Biotech to Roche

Lonza says it has agreed to license its glutamine synthetase (GS) expression system and GS-CHO protein free system to Roche for the manufacture of therapeutic recombinant proteins and monoclonal antibodies. Financial terms were not disclosed. The agreement builds on a supply agreement between Lonza and Roche for undisclosed...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers